NIPPON SHOKUBAI CO., LTD.

EPOSTAR™ MV Series acts as anti-blocking, light-diffusion, matting, and void-forming agents. They are polymethyl methacrylate-based, crosslinked, perfectly spherical fine particles. They exhibit excellent heat- and solvent resistance, and excellent dispersibility for resins (polyolefin etc.) and solvent. Product page on our website: https://lnkd.in/gExgmCSH Case study on SpecialChem site: https://lnkd.in/gmcScr_k

EPOSTAR™ Series are used for light diffusion, toner additives, and matting agents. They are heat-cured, spherical fine particles with melamine and benzoguanamine resins as raw materials. They possess high refractive index and positive charge due to high density nitrogen atom, offering excellent heat and solvent resistance. Product page on our web site. https://lnkd.in/g2g3Mj8B Case study on SpecialChem https://lnkd.in/g9JxU7wc

Nippon Shokubai Announces Distribution Agreement with the University of Manchester -Initiated Startup Holiferm We has signed a distribution agreement with Holiferm for biosurfactants as cosmetic ingredients. This distribution agreement for this novel range of eco-friendly surfactants is applicable in the personal care market in Japan. We will continue to expand its cosmetics business in Japan and overseas, not only with our own materials but also new materials developed via external collaboration. Please check the details from the following URL. https://lnkd.in/eEcQByEV Picture: Examples of Holiferm’s biosurfactant products

新機能性材料展2025に出展中です。2日目も多くの方にお立ち寄りいただいております。写真に写っているもの以外にも、海洋生分解性プラスチック、高吸水性樹脂など、さまざまな素材、技術をご紹介。 東京ビッグサイト東ホール・マテリアルゾーン5F-16にて、お待ちしております。 We are exhibiting at the neo functional material 2025, and many visitors are stopping by. In addition to the products shown in the photos, we are introducing various materials and technologies such as marine biodegradable plastics and superabsorbent polymers. We look forward to seeing you at Tokyo Big Sight, East Hall, Material Zone 5F-16.

3D Cell Culture Vessel “MicoCell™” First Application in Regenerative Medicine Regenerative medicine treatments utilizing “MicoCell™” developed by Nippon Shokubai(Headquarters: Osaka, Japan, President: Kazuhiro Noda) have commenced at Saiseikai Sobajima Clinic and Research Institute (Location: Osaka, Japan, President and Medical Director: Satoshi Sobajima). MicoCell™ is a 3D cell culture vessel developed by Nippon Shokubai using its proprietary technology. Unlike conventional 3D floating culture vessels and 2D culture vessels, the surface of this culture vessel is made of a material designed to enable weak cell adhesion, thereby replicating an environment similar to that in vivo. When disaggregated cells are introduced, they bind to each other three-dimensionally and form uniformly sized aggregates (spheroids). This allows for the easy production of large quantities of high-quality cell aggregates, which are necessary for regenerative medicine, drug screening, and other drug discovery research. Please check the details from the following URL https://lnkd.in/e_sTt-gt

新機能性材料展2025に出展いたします。 海洋生分解性プラスチック（初出展）、耐熱透明樹脂、高吸水性樹脂の３つの樹脂素材と、レーザー溶着用色素や水系架橋剤などコーティング・接着用途で力を発揮する４つの機能素材を展示。お客様の新しい可能性を広げる素材をラインアップしております。素材の紹介動画やサンプルを準備してご来場をお待ちしています。 #新機能性材料展

We are pleased to announce that we will exhibit at the Neo Functional Materials Expo! We will exhibit water-based crosslinking agents with reduced curing temperatures, UV-curable monomers, laser absorbent materials that enable clean welding of resins, marine biodegradable plastics that can add biodegradability to other resins, water absorbent resins with a leading market share, heat-resistant transparent resins, and other products. #新機能性材料展　#NeoFunctionalMaterial

Discover SEAHOSTAR™ Grades - Advanced Silica Solutions for High-Performance Applications.   Here is a new case study on SEAHOSTAR™ KE Series on SpecialChem. https://lnkd.in/gbp8XDXm   SEAHOSTAR™ KE Series are mainly used as anti-blocking agents and resin fillers. They are non-crystalline spherical fine particle of silica with narrow particle size distribution. SEAHOSTAR™ KE Series exhibit high purity and exist as primary particles with few secondary aggregates. They are suitable for LCD/OLED sealing and semiconductor encapsulation materials.   For the basic information on SEAHOSTAR™, visit our we page on https://lnkd.in/gADZR5YR   #silica #fillers #antiblocking #SpecialChem

Discover SEAHOSTAR™ Grades - Advanced Silica Solutions for High-Performance Applications.   Here is a new case study on SEAHOSTAR™ KE Series on SpecialChem. https://lnkd.in/gbp8XDXm   SEAHOSTAR™ KE Series are mainly used as anti-blocking agents and resin fillers. They are non-crystalline spherical fine particle of silica with narrow particle size distribution. SEAHOSTAR™ KE Series exhibit high purity and exist as primary particles with few secondary aggregates. They are suitable for LCD/OLED sealing and semiconductor encapsulation materials.   For the basic information on SEAHOSTAR™, visit our we page on https://lnkd.in/gADZR5YR   #silica #fillers #antiblocking #SpecialChem

Nippon Shokubai announces shares acquisition of Lilac pharma (to make it a subsidiary) Nippon Shokubai has announced to acquire all shares of Lilac pharma Inc., to make Lilac pharma a 100% subsidiary on December 9, 2024. Lilac pharma which is a Hokkaido University-initiated startup, is developing its business based on lipid nanoparticle manufacturing technology focusing on the size of lipid nanoparticles. Their own “iLiNP Microfluidic Device” is different from conventional method, can continuously produce high-quality lipid nanoparticles of uniform size easily. Furthermore, since the size can be controlled widely, iLiNP is expected to be a technology for manufacturing highly functional lipid nanoparticles and is being provided for cosmetics and pharmaceuticals. Nippon Shokubai and Lilac pharma have successfully developed liposomes for cosmetics with characteristics such as extremely high stability through joint research since 2019.  By making Lilac pharma a 100% subsidiary, Nippon Shokubai will accelerate the development efficiency of liposomes and the establishment of a stable supply system, and aim to further expand its cosmetics and nanoparticle business for pharmaceuticals by utilizing the expertise in various fields. ※iLiNP is a trademark of Lilac pharma https://lnkd.in/e47uMN9C